Literature DB >> 12467808

Thyroid hormones levels in infants during and after cardiopulmonary bypass with ultrafiltration.

R Bartkowski1, M Wojtalik, E Korman, G Sharma, J Henschke, W Mrówczyński.   

Abstract

OBJECTIVE: The aim of this study was to find out if infants after cardiopulmonary bypass develop non-thyroidal illness and if illness severity after cardiopulmonary bypass depends on hormone concentration in ultrafiltrate.
METHODS: Thyroid hormone status was assessed in 20 infants with congenital heart defects undergoing cardiac surgery (age range 7 days-11 months). Blood samples were collected preoperatively, during cardiopulmonary bypass, after cardiopulmonary bypass, and also postoperatively in 1, 2, 3, and 8 day after cardiac surgery. Plasma thyrotropin, thyroxine, free thyroxine, triiodothyronine, free triiodothyronine and reverse triiodothyronine were measured in blood samples and also in ultrafiltrate.
RESULTS: All patients had reduction in serum thyrotropin, thyroxine, free thyroxine, triiodothyronine, free triiodothyronine, and elevation of reverse triiodothyronine after cardiac surgery. In all patients we performed ultrafiltration. Patients were divided in to two groups. (with and without prolonged recovery). In the group of patients with prolonged recovery we noticed significantly higher amount of triiodothyronine per kilogram body weight. One of these patients died. The average level of total thyroxine decreased from the level 126 nmol/l before bypass to the minimal level 73 nmol/l after bypass, free thyroxine from the level 18 pmol/l before bypass to the minimal level 12 pmol/l after bypass. The average level of total triiodothyronine decreased from the level 1.54 nmol/l before bypass to the minimal level 0.42 nmol/l after bypass, free triiodothyronine from the level 6.12 pmol/l before bypass to the minimal level 3.21 pmol/l after bypass. The average level of TSH decreased from the level 4.31 mU/l before bypass to the level 0.64 mU/l after bypass. The average level of reverse-triiodothyronine increase from the level 0.83 nmol/l before bypass to the maximal level 1.94 nmol/l after bypass.
CONCLUSIONS: We conclude that non-thyroidal illness occurs in all infants after cardiopulmonary bypass. The amount of free triiodothyronine that is filtrated during cardiopulmonary bypass may influence postoperative recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467808     DOI: 10.1016/s1010-7940(02)00588-2

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Endocrinologic Diseases in Pediatric Cardiac Intensive Care.

Authors:  Carmen L Soto-Rivera; Steven M Schwartz; Jaclyn E Sawyer; Duncan J Macrae; Michael S D Agus
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

2.  Identifying infants at risk of marked thyroid suppression post-cardiopulmonary bypass.

Authors:  Kevin Plumpton; Nikolaus A Haas
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

3.  Thyroid hormone and cortisol concentrations after congenital heart surgery in infants younger than 3 months of age.

Authors:  Kevin R Plumpton; Brian J Anderson; John Beca
Journal:  Intensive Care Med       Date:  2009-10-07       Impact factor: 17.440

4.  A prospective randomized clinical study of perioperative oral thyroid hormone treatment for children undergoing surgery for congenital heart diseases.

Authors:  Alok Kumar; Nikhil Tiwari; Harpanahalli Ravi Ramamurthy; Vivek Kumar; Gaurav Kumar
Journal:  Ann Pediatr Cardiol       Date:  2021-02-16

Review 5.  Clinical review: thyroid hormone replacement in children after cardiac surgery--is it worth a try?

Authors:  Nikolaus A Haas; Christoph K Camphausen; Deniz Kececioglu
Journal:  Crit Care       Date:  2006-05-23       Impact factor: 9.097

6.  Effect of perioperative use of oral triidothyronine for infants undergoing complex congenital cardiac surgeries under cardiopulmonary bypass: A double-blinded randomised controlled study.

Authors:  Sujithareddy Karri; Banashree Mandal; Bhupesh Kumar; Goverdandutt Puri; Shyam Thingnam; Hemant Kumar; V S Unnikrishnan
Journal:  Ann Card Anaesth       Date:  2022 Jul-Sep

7.  Non-thyroidal illness syndrome and cardiopulmonary bypass in children with congenital heart disease.

Authors:  Kazem Babazadeh; Avisa Tabib; Peyman Eshraghi; Hooman Bakhshandeh; Hassan Zamani
Journal:  Caspian J Intern Med       Date:  2014

8.  Preoperative oral thyroid hormones to prevent euthyroid sick syndrome and attenuate myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass in children: A randomized, double-blind, placebo-controlled trial.

Authors:  Jia-Qiang Zhang; Quan-Yong Yang; Fu-Shan Xue; Wei Zhang; Gui-Zhen Yang; Xu Liao; Fan-Min Meng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.